A stem cell competitor of SVFC had their stock beaten down to .0002, before starting a major run in mid-dec, announcing a major funding deal and distribution of stock of a separate entity... Stock topped out at 1.7 cents two months after run began...
Share structure is a little worse here, but the connections and attachments are much better leading to better potential a investor penetration..
Remember the 15 million Andrews accelerator.. Same 15 million in Dawson James deal noted with preferred shares...
Wonder why the CD holders have been so cordial with conversions until just the past month when everybody needed to convert???
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.